Thus, the expansion of knowledge of the cost–benefit of applying screening and antifungal therapy in this CD4 stratum, combined with primary care in the administration of ART worldwide, is extremely necessary to disseminate the application of antigen testing in regions with high disease prevalence to prevent severe sequelae and deaths from cryptococcosis. The gene discussed is CD4; the disease is cryptococcosis.